Commission Regulation (EU) 2021/1902 of 29 October 2021 amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use in cosmetic products of certain substances classified as carcinogenic, mutagenic or toxic for reproduction (Text with EEA relevance)

• CELEX: Regulation (EU) 2021/1902
• Articles: 3

Article 1

Annexes II, III and V to Regulation (EC) No 1223/2009 are amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 1 March 2022.

Schedules & Appendices

ANNEX

ANNEX

Annexes II, III and V to Regulation (EC) No 1223/2009 are amended as follows:

(1)

in Annex II, the following entries are added:

Reference number

Substance identification

Chemical name/INN

CAS number

EC number

a

b

c

d

‘1658

Silicon carbide fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1)

409-21-2

308076-74-6

206-991-8

1659

Tris(2-methoxyethoxy) vinylsilane; 6-(2-methoxyethoxy)- 6-vinyl-2,5,7,10-tetraoxa-6-silaundecane

1067-53-4

213-934-0

1660

Dioctyltin dilaurate; [1]

stannane, dioctyl-, bis (coco acyloxy) derivs. [2]

3648-18-8 [1]

91648- 39-4 [2]

222-883-3 [1]

293-901-5 [2]

1661

Dibenzo[def,p]chrysene; dibenzo[a,l]pyrene

191-30-0

205-886-4

1662

Ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1- (1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

125225-28-7

115850-69-6

115937-89-8

-

1663

Bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme

143-24-8

205-594-7

1664

Paclobutrazol (ISO); (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl- 2-(1H-1,2,4-triazol-1- yl)pentan-3-ol

76738-62-0

-

1665

2,2-bis(bromomethyl) propane-1,3-diol

3296-90-0

221-967-7

1666

2-(4-tert-butylbenzyl) propionaldehyde

80-54-6

201-289-8

1667

Diisooctyl phthalate

27554-26-3

248-523-5

1668

2-methoxyethyl acrylate

3121-61-7

221-499-3

1669

Sodium N-(hydroxymethyl)glycinate; [formaldehyde released from sodium N-(hydroxymethyl)glycinate]

if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w

70161-44-3

274-357-8

1670

Pyrithione zinc; (T-4)- bis[1-(hydroxy-.kappa.O)pyridine-2(1H)- thionato-.kappa.S]zinc

13463-41-7

236-671-3

1671

Flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one

61213-25-0

262-661-3

1672

3-(difluoromethyl)-1- methyl-N-(3',4',5'-trifluorobiphenyl-2-yl) pyrazole-4-carboxamide; fluxapyroxad

907204-31-3

-

1673

N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA]

924-42-5

213-103-2

1674

5-fluoro-1,3-dimethyl-N-[2-(4- methylpentan-2-yl) phenyl]-1H-pyrazole- 4-carboxamide; 2'- [(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen

494793-67-8

-

1675

Iprovalicarb (ISO); isopropyl [(2S)-3- methyl-1-{[1-(4- methylphenyl)ethyl] amino}-1-oxobutan-2- yl]carbamate

140923-17-7

-

1676

Dichlorodioctylstannane

3542-36-7

222-583-2

1677

Mesotrione (ISO); 2-[4-(methylsulfonyl)- 2-nitrobenzoyl]-1,3- cyclohexanedione

104206-82-8

-

1678

Hymexazol (ISO); 3-hydroxy-5-methylisoxazole

10004-44-1

233-000-6

1679

Imiprothrin (ISO); reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate

72963-72-5

428-790-6

1680

Bis(α,α-dimethylbenzyl) peroxide

80-43-3;

201-279-3’

(2)

in Annex III is amended as follows:

(a)

entry 24 is replaced by the following:

Reference number

Substance identification

Restrictions

Wording of conditions of use and warnings

Chemical Name/INN

Name of Common Ingredients Glossary

CAS number

EC number

Product type, Body parts

Maximum concentration in ready for use preparation

Other

a

b

c

d

e

f

g

h

i

‘24

Water-soluble zinc salts with the exception of zinc 4- hydroxy-benzenesulphonate (entry 25) and zinc pyrithione (Annex II, entry X)

Zinc acetate,

zinc chloride, zinc gluconate, zinc glutamate

1 % (as zinc)’

(b)

entries 83 and 101 are deleted;

(3)

Annex V is amended as follows:

(a)

entry 8 is deleted;

(b)

entry 51 is replaced by the following:

Reference number

Substance identification

Conditions

Wording of conditions of use and warnings

Chemical name/INN

Name of Common Ingredients Glossary

CAS number

EC number

Product type, Body parts

Maximum concentration in ready for use preparation

Other

a

b

c

d

e

f

g

h

i

‘51

Sodium hydroxymethylamino acetate

Sodium Hydroxymethylglycinate

70161-44-3

274-357-8

0,5 %

Not to be used if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, if the mixture as placed on the market is ≥ 0,1 % w/w’